טוען...
Intravenous Glucocorticoid Treatment for Korean Graves' Ophthalmopathy Patients
BACKGROUND: High-dose intravenous steroids are the first-line treatment for patients with moderate-to-severe and active Graves' ophthalmopathy (GO). We aimed to investigate the response rate of methylprednisolone (MPD) treatment among Korean patients with active moderate-to-severe GO and to ide...
שמור ב:
| הוצא לאור ב: | J Korean Med Sci |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Academy of Medical Sciences
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7295605/ https://ncbi.nlm.nih.gov/pubmed/32537950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e177 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|